Kore Private Wealth’s Microbot Medical MBOT Stock Holding History

Kore Private Wealth’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-225	Closed	-$1K	–	1222
2020 Q1	$1K	Hold	225	–	–	﹤0.01%	1001
2019 Q4	$2K	Buy	+225	New	+$1.32K	﹤0.01%	934

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kore Private Wealth's MBOT Position: Q2 2020 in Review

Kore Private Wealth sold out of Microbot Medical (MBOT) in Q2 2020, closing a stake of 225 shares — an estimated $1K sold.

Kore Private Wealth first reported a position in MBOT in Q4 2019 and held it in 2 quarters. The position peaked at $2K in Q4 2019. 23 funds tracked by Wall St. Rank hold MBOT as of Q2 2020.

Kore Private Wealth reported no remaining Microbot Medical position as of Q2 2020 after selling out during the quarter.
Kore Private Wealth sold 225 Microbot Medical shares in Q2 2020, an estimated $1K.
Kore Private Wealth first reported a position in Microbot Medical in Q4 2019 and held it in 2 quarters.
Kore Private Wealth's Microbot Medical position peaked at $2K in Q4 2019.
23 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2020.

Based on Kore Private Wealth's 13F filing for Q2 2020, filed 14 Aug 2020.